http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107569681-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2017-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107569681-B
titleOfInvention Bivalent inactivated vaccine for bovine pasteurellosis and preparation method thereof
abstract The invention relates to a bivalent inactivated vaccine for cattle pasteurellosis, belonging to the technical field of preparation of biological products for livestock. The bivalent inactivated vaccine comprises an antigen and a vaccine adjuvant, wherein the antigen is a bovine pasteurella multocida capsular type A Pm-TJ strain and a bovine pasteurella multocida capsular type B C45-2 strain. The bivalent inactivated vaccine prepared by the invention adopts a concentration and purification process, optimizes a fermentation culture process of a bovine pasteurella multocida capsular type B C45-2 strain, shortens the fermentation time by more than half, improves the production efficiency, can simultaneously prevent bovine cellulosic suppurative pneumonia and bovine hemorrhagic septicemia caused by bovine pasteurella multocida infection through one-needle immunization, and has the characteristics of safety, reliability and good immune effect.
priorityDate 2017-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452490286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16684434

Total number of triples: 15.